Flowflex SARS-CoV-2 Antigen Rapid Nasal Test
Flowflex SARS-CoV-2 Antigen Rapid Nasal Test
Flowflex SARS-CoV-2 Antigen Rapid Nasal Test
VAT EXEMPT

Flowflex SARS-CoV-2 Antigen Rapid Nasal Test

Regular price €3.00 €0.00 Unit price per
Tax Included.

This item is VAT excluded. Ex-VAT price is automatically generated.

Your invoice is the full price shown. 

Delivery charges may apply! 

The SARS-CoV-2 Antigen Rapid Test is a lateral flow test for the qualitative detection of the nucleocapsid antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals suspected of COVID-1R within the first seven days of the onset of symptoms.

The test can also test specimens from individuals without symptoms.

  • Specimen: Anterior nasal swab specimens
  • Test Time: Results in 15 min
  • Shelf life: 24 months
  • Storage temperature: 2-30oC
  • Accuracy: 98.8%
  • Sensitivity: 97.1%
  • Specificity: 99.5%
  • Single-used. Single patient only. 
  • This item is non-returnable.
  • Test kit is approved by the EU Health Security Committee (page 12) and CE certified.

 Watch video on how to perform the test

Contact us directly at info@marathonsafetysolutions.ie for bulk pricing

Free, tracked DPD delivery for orders of €40 and more. 
Minimum delivery charge, €5.

DELIVERY TIME
Ireland - 24/48 hrs (DPD)
UK - 48/72 hrs via courier
Ireland - 3 - 5 days with standard An Post 

Secure Payment 
Refund and Return Policy
Contact Us – Marathon Safety Solutions

Marathon Safety Solutions - Irish owned, Dublin based. 

NOTE: Results are for the identification of SARS-CoV-2 nucleocapsid antigen.  The positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. The positive results do not rule out bacterial infection or co-infection with other viruses. 
The negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. 


Share this Product